Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DML2E8S)

Drug Name
Pyrimidinyl compound 6 Drug Info
Synonyms PMID26293650-Compound-41
Cross-matching ID
PubChem CID
66685711
TTD Drug ID
DML2E8S

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting NF-kappa-B-activating kinase (TBK1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID26293650-Compound-34 DMHXT12 N. A. N. A. Patented [1]
PMID26293650-Compound-35 DMPG8MF N. A. N. A. Patented [1]
Pyrimidinyl compound 4 DM53O9Y N. A. N. A. Patented [1]
Aminopyrimidine derivative 10 DM2TF64 N. A. N. A. Patented [1]
Pyrimidinyl compound 7 DMMYW2L N. A. N. A. Patented [1]
Pyrimidinyl compound 1 DMYKHQ8 N. A. N. A. Patented [1]
Aminopyrimidine derivative 7 DMW98RI N. A. N. A. Patented [1]
Pyrimidinyl compound 3 DMOE2FZ N. A. N. A. Patented [1]
Aminopyrimidine derivative 9 DM5VRXW N. A. N. A. Patented [1]
Pyrimidinyl compound 2 DM9TW5O N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
NF-kappa-B-activating kinase (TBK1) TTH5TC2 TBK1_HUMAN Inhibitor [1]

References

1 TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96.